[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-342294-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-342294-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-molecular-features-of-lung-cancer-stem-cells-in-dedifferentiation-process-driven-epigenetic-alterations-reviews","The molecular features of lung cancer stem cells in dedifferentiation process-driven epigenetic alterations - Reviews","","Cancer stem cells (CSCs) are described as a dedifferentiated, oncogenesis-linked cell subpopulation capable of proliferation and self-renewal, driving lineage heterogeneity and contributing to therapy resistance. The review explains bidirectional CSC/non-CSC interconversion and how less differentiated processes promote tumor plasticity through epigenetic reprogramming, signaling pathway activation, and driver mutations. It focuses on key epigenetic alterations and molecular mechanisms in lung cancer that support tailored therapeutic strategies.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-molecular-features-of-lung-cancer-stem-cells-in-dedifferentiation-process-driven-epigenetic-alterations-reviews/342294/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-molecular-features-of-lung-cancer-stem-cells-in-dedifferentiation-process-driven-epigenetic-alterations-reviews/342294.png","ImageObject",300,407,{"name":42,"@type":43},"Aurelia","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the proposed role of cancer stem cells in lung cancer therapy resistance?","Question",{"text":63,"@type":64},"The review states that CSCs can promote tumor growth through proliferation and self-renewal and may underlie resistance to therapies by driving lineage heterogeneity and tumor plasticity.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does dedifferentiation relate to CSC identity according to the review?",{"text":68,"@type":64},"Dedifferentiation is presented as the process where tumor cells revert from a partially or terminally differentiated state to a less differentiated, cell-cycle re-entering, stem-like phenotype with stem cell marker expression.",{"name":70,"@type":61,"acceptedAnswer":71},"Which molecular elements does the review emphasize for lung cancer?",{"text":72,"@type":64},"It highlights major epigenetic alterations, key signaling pathways, and driver mutations that could be involved in the differentiation/dedifferentiation process and inform more tailored treatments.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},342294,1790192685,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":109,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},1099514068365,"https://ap-avatar.wpscdn.com/avatar/10000253d8d9f28188e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1794309523707217728","REVIEWS  \nThe molecular features of lung cancer stem cells indedifferentiation process-driven epigenetic alterations  \nReceived for publication, March 23, 2024, and in revised form, October 30, 2024 Published, Papers in Press, November 14, 2024, [https://doi.org/10.1016/j.jbc.2024.107994](https://doi.org/10.1016/j.jbc.2024.107994)  \nValentina Masciale 1,§, Federico Banchelli2,§, Giulia Grisendi 1, Anna Valeria Samarelli3, Giulia Raineri 1, Tania Rossi4, Michele Zanoni4, Michela Cortesi4, Sara Bandini4, Paola Ulivi4, Giovanni Martinelli4, Franco Stella5,  \nMassimo Dominici 1,6,‡, and Beatrice Aramini5, *,‡  \nFrom the 1Laboratory of Cellular Therapies, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena, Modena, Italy; 2Department of Statistical Sciences \"Paolo Fortunati\", Alma Mater Studiorum- University of Bologna, Bologna, Modena, Italy; 3Laboratory of and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena, Modena, Italy; 4Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \"Dino Amadori\", Meldola, Italy; 5Thoracic Surgery Unit, Department of Medical and Surgical Sciences-DIMEC of the Alma Mater Studiorum, University of Bologna, G.B. Morgagni-L. Pierantoni Hospital, Forlì, Italy; 6Division of Oncology, University Hospital of Modena and Reggio Emilia, University of Modena and Reggio Emilia, Modena, Italy  \nReviewed by members of the JBC Editorial Board. Edited by Alex Toker  \nCancer stem cells (CSCs) may be dedifferentiated somatic cells following oncogenic processes, representing a subpopulation of cells able to promote tumor growth with their capacities for proliferation and self-renewal, inducing lineage heterogeneity, which may be a main cause of resistance to therapies. It has been shown that the “less differentiated process” may have an impact on tumor plasticity, particularly when non-CSCs may dedifferentiate and become CSC-like. Bidirectional interconversion between CSCs and non-CSCs has been reported in other solid tumors, where the inﬂammatory stroma promotes cell reprogramming by enhancing Wnt signaling through nuclear factor kappa B activation in association with intracellular signaling, which may induce cells’ pluripotency, the oncogenic transformation can be considered another important aspect in the acquisition of“new” development programs with oncogenic features. During cell reprogramming, mutations represent an initial step toward dedifferentiation, in which tumor cells switch from a partially or terminally differentiated stage to a less differentiated stage that is mainly manifested by re-entry into the cell cycle, acquisition of a stem cell-like phenotype, and expression of stem cell markers. This phenomenon typically shows up as a change in the form, function, and pattern of gene and protein expression, and more speciﬁcally, in CSCs. This review would highlight the main epigenetic alterations, major signaling pathways and driver mutations in which CSCs, in tumors and speciﬁcally, in lung cancer, could be involved, acting as key elements in the differentiation/dedifferentiation process. This would highlight the main molecular mechanisms which need to be considered for more tailored therapies.  \n‡ Co-last authorship.  \n§ Co-ﬁrst authorship.  \n* For correspondence: Beatrice Aramini, [beatrice.aramini2@unibo.it](beatrice.aramini2@unibo.it).  \nLung cancer is considered one of the most debated unsolved health problems globally, representing 19.4% of all tumors, and causing death for 1.59 million people (1). In recent years, thescientiﬁc community has deﬁned solid tumors as a mix of cells with different activities and properties (2). Although new approaches have been set for local and advanced diseases, lung cancer has a strong tendency to recur, suggesting the possible presence of a cell population that develops resistance against standard treatments (3). Cells with this pe","cbCaiaNnf8c9YkdE","https://ap.wps.com/l/cbCaiaNnf8c9YkdE","pdf",3185136,"English","# Reviews\n## Cancer stem cells, dedifferentiation, and therapy resistance\n## Bidirectional interconversion and tumor plasticity\n## Epigenetic alterations, signaling pathways, and driver mutations\n## Implications for tailored lung cancer therapies","[{\"question\":\"What is the proposed role of cancer stem cells in lung cancer therapy resistance?\",\"answer\":\"The review states that CSCs can promote tumor growth through proliferation and self-renewal and may underlie resistance to therapies by driving lineage heterogeneity and tumor plasticity.\"},{\"question\":\"How does dedifferentiation relate to CSC identity according to the review?\",\"answer\":\"Dedifferentiation is presented as the process where tumor cells revert from a partially or terminally differentiated state to a less differentiated, cell-cycle re-entering, stem-like phenotype with stem cell marker expression.\"},{\"question\":\"Which molecular elements does the review emphasize for lung cancer?\",\"answer\":\"It highlights major epigenetic alterations, key signaling pathways, and driver mutations that could be involved in the differentiation/dedifferentiation process and inform more tailored treatments.\"}]","The molecular features of lung cancer stem cells in dedifferentiation process-driven epigenetic alterations - Reviews | PDF",1790046040,101,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/06e111433157b21ba7953801a3213cd1.webp",983,1296,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/062627ad55716d9b610d836f0bc74e1f.webp",982,1294,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9d711b61e4dd336761309b5689f5c8c1.webp",981,1293,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4a5c63731501a0fd2ee0e2b064dba91d.webp",980,1292]